解码先天性心脏病:对心脏血统和调节功能障碍的多组框架
Huasheng Lv1, Fengyu Sun2, You Chen1
1Department of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Frontiers in cell and developmental biology
|October 6, 2025
概括
像单细胞测序这样的新技术正在彻底改变先天性心脏病 (CHD) 研究. 这种转变使得对特定细胞类型的遗传风险能够准确地绘制地图,为更好的诊断和治疗铺平了道路.
科学领域:
- 发展生物学 发展生物学
- 遗传学 是一个遗传学.
- 心血管研究研究心血管研究
背景情况:
- 在全球范围内,先天性心脏病 (CHD) 是最常见的出生缺陷.
- 传统的遗传模型没有足够的分辨率来充分理解心血管疾病的复杂起源.
- 心脏发育中的障碍会导致发育不良.
研究的目的:
- 审查先进的单细胞和多细胞技术如何改变CHD研究.
- 综合目前对心脏前体细胞在心脏病发育的理解.
- 突出用于建模和理解CHD的新方法.
主要方法:
- 单细胞RNA测序的一个细胞.
- 空间转录组学 空间转录组学
- 综合多主题综合性多主题
- 全基因组关联研究研究.
- 心脏类有机物质是什么心脏有机物质
- 工程开发的发展模型.
主要成果:
- 高分辨率分析揭示了心血管疾病的细胞起源和调节格局.
- 非编码风险变异可以映射到特定的细胞状态和发育时间.
- 有机和工程模型允许对基因缺陷的功能验证.
结论:
- 先进的技术正在使一种机械的,细胞类型解决的对CHD的理解成为可能.
- 这种范式转变为精确诊断和向治疗开辟了新的途径.
- 未来的研究重点是通过再生方法恢复正常的心脏发育.
相关概念视频
Cardiomyopathy I: Introduction and Classification
502
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
502
Pathophysiology of Cardiac Performance
1.4K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.4K
Cardiomyopathy IV: Restrictive Cardiomyopathy
453
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
453
Cardiomyopathy III: Hypertrophic Cardiomyopathy
401
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401
Development of the Heart
2.1K
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
2.1K
Cardiomyopathy II: Dilated Cardiomyopathy
468
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468


